Benjamin Landry - 01 May 2023 Form 3 Insider Report for Health Catalyst, Inc. (HCAT)

Role
General Counsel
Signature
/s/ Benjamin Landry
Issuer symbol
HCAT
Transactions as of
01 May 2023
Net transactions value
$0
Form type
3
Filing time
04 May 2023, 16:32:55 UTC
Next filing
04 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HCAT Common Stock 937 01 May 2023 Direct F1
holding HCAT Common Stock 4,375 01 May 2023 Direct F2
holding HCAT Common Stock 6,187 01 May 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on September 1, 2020 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.
F2 Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on December 1, 2021 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.
F3 Represents an award of RSUs granted pursuant to the 2019 Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs vested on December 1, 2022 and the remaining 75% of the RSUs vested or will vest in 12 equal quarterly installments.